177 related articles for article (PubMed ID: 32236960)
1. Pharmacogenomic-Based Decision Support to Predict Adherence to Medications.
Christian C; Borden BA; Danahey K; Yeo KJ; van Wijk XMR; Ratain MJ; O'Donnell PH
Clin Pharmacol Ther; 2020 Aug; 108(2):368-376. PubMed ID: 32236960
[TBL] [Abstract][Full Text] [Related]
2. Analysis of comprehensive pharmacogenomic profiling to impact in-hospital prescribing.
Lee YM; Danahey K; Knoebel RW; Ratain MJ; Meltzer DO; O'Donnell PH
Pharmacogenet Genomics; 2019 Feb; 29(2):23-30. PubMed ID: 30531378
[TBL] [Abstract][Full Text] [Related]
3. Pharmacogenomics-Based Point-of-Care Clinical Decision Support Significantly Alters Drug Prescribing.
O'Donnell PH; Wadhwa N; Danahey K; Borden BA; Lee SM; Hall JP; Klammer C; Hussain S; Siegler M; Sorrentino MJ; Davis AM; Sacro YA; Nanda R; Polonsky TS; Koyner JL; Burnet DL; Lipstreuer K; Rubin DT; Mulcahy C; Strek ME; Harper W; Cifu AS; Polite B; Patrick-Miller L; Yeo KT; Leung E; Volchenboum SL; Altman RB; Olopade OI; Stadler WM; Meltzer DO; Ratain MJ
Clin Pharmacol Ther; 2017 Nov; 102(5):859-869. PubMed ID: 28398598
[TBL] [Abstract][Full Text] [Related]
4. Pilot Findings of Pharmacogenomics in Perioperative Care: Initial Results From the First Phase of the ImPreSS Trial.
Truong TM; Apfelbaum JL; Danahey K; Schierer E; Ludwig J; George D; House L; Karrison T; Shahul S; Anitescu M; Choksi A; Hartman S; Knoebel RW; van Wijk XMR; Yeo KJ; Meltzer DO; Ratain MJ; O'Donnell PH
Anesth Analg; 2022 Nov; 135(5):929-940. PubMed ID: 35213469
[TBL] [Abstract][Full Text] [Related]
5. Patient-provider communications about pharmacogenomic results increase patient recall of medication changes.
Borden BA; Lee SM; Danahey K; Galecki P; Patrick-Miller L; Siegler M; Sorrentino MJ; Sacro Y; Davis AM; Rubin DT; Lipstreuer K; Polonsky TS; Nanda R; Harper WR; Koyner JL; Burnet DL; Stadler WM; Kavitt RT; Meltzer DO; Ratain MJ; O'Donnell PH
Pharmacogenomics J; 2019 Dec; 19(6):528-537. PubMed ID: 30713337
[TBL] [Abstract][Full Text] [Related]
6. Analyzing the clinical actionability of germline pharmacogenomic findings in oncology.
Wellmann R; Borden BA; Danahey K; Nanda R; Polite BN; Stadler WM; Ratain MJ; O'Donnell PH
Cancer; 2018 Jul; 124(14):3052-3065. PubMed ID: 29742281
[TBL] [Abstract][Full Text] [Related]
7. Impact and applicability of pharmacogenomics in rheumatology: an integrated analysis.
Reid P; Danahey K; Lopez Velazquez M; Ratain MJ; O'Donnell PH
Clin Exp Rheumatol; 2021; 39(6):1385-1393. PubMed ID: 33506753
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenomic potential in advanced cancer patients.
Nichols D; Arnold S; Weiss HL; Wu J; Durbin EB; Miller R; Kolesar J
Am J Health Syst Pharm; 2019 Mar; 76(7):415-423. PubMed ID: 31361818
[TBL] [Abstract][Full Text] [Related]
9. Advancing Pharmacogenomics from Single-Gene to Preemptive Testing.
Haidar CE; Crews KR; Hoffman JM; Relling MV; Caudle KE
Annu Rev Genomics Hum Genet; 2022 Aug; 23():449-473. PubMed ID: 35537468
[TBL] [Abstract][Full Text] [Related]
10. Assessment of provider-perceived barriers to clinical use of pharmacogenomics during participation in an institutional implementation study.
Borden BA; Galecki P; Wellmann R; Danahey K; Lee SM; Patrick-Miller L; Sorrentino MJ; Nanda R; Koyner JL; Polonsky TS; Stadler WM; Mulcahy C; Kavitt RT; Ratain MJ; Meltzer DO; O'Donnell PH
Pharmacogenet Genomics; 2019 Feb; 29(2):31-38. PubMed ID: 30531377
[TBL] [Abstract][Full Text] [Related]
11. Appraisal and development of evidence-based clinical decision support to enable perioperative pharmacogenomic application.
Borden BA; Jhun EH; Danahey K; Schierer E; Apfelbaum JL; Anitescu M; Knoebel R; Shahul S; Truong TM; Ratain MJ; O'Donnell PH
Pharmacogenomics J; 2021 Dec; 21(6):691-711. PubMed ID: 34376788
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenomics in kidney transplant recipients and potential for integration into practice.
Nguyen TT; Pearson RA; Mohamed ME; Schladt DP; Berglund D; Rivers Z; Skaar DJ; Wu B; Guan W; van Setten J; Keating BJ; Dorr C; Remmel RP; Matas AJ; Mannon RB; Israni AK; Oetting WS; Jacobson PA
J Clin Pharm Ther; 2020 Dec; 45(6):1457-1465. PubMed ID: 32662547
[TBL] [Abstract][Full Text] [Related]
13. Attitudes of clinicians following large-scale pharmacogenomics implementation.
Peterson JF; Field JR; Shi Y; Schildcrout JS; Denny JC; McGregor TL; Van Driest SL; Pulley JM; Lubin IM; Laposata M; Roden DM; Clayton EW
Pharmacogenomics J; 2016 Aug; 16(4):393-8. PubMed ID: 26261062
[TBL] [Abstract][Full Text] [Related]
14. Veterans Health Administration: Implementation of pharmacogenomic clinical decision support with statin medications and the SLCO1B1 gene as an exemplar.
Tomcsanyi KM; Tran KA; Bates J; Cunningham FE; Silverman R; Norris AK; Moore VR; Voora D
Am J Health Syst Pharm; 2023 Aug; 80(16):1082-1089. PubMed ID: 37210707
[TBL] [Abstract][Full Text] [Related]
15. Factors influencing the impact of pharmacogenomic prescribing on adherence to nicotine replacement therapy: A qualitative study of participants from a randomized controlled trial.
Wright AJ; Sutton S; Armstrong D; Aveyard P; Kinmonth AL; Marteau TM
Transl Behav Med; 2018 Jan; 8(1):18-28. PubMed ID: 29385578
[TBL] [Abstract][Full Text] [Related]
16. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
[TBL] [Abstract][Full Text] [Related]
17. How to Transition from Single-Gene Pharmacogenetic Testing to Preemptive Panel-Based Testing: A Tutorial.
Marrero RJ; Cicali EJ; Arwood MJ; Eddy E; DeRemer D; Ramnaraign BH; Daily KC; Jones D; Cook KJ; Cavallari LH; Wiisanen Weitzel K; Langaee T; Newsom KJ; Starostik P; Clare-Salzer MJ; Johnson JA; George TJ; Cooper-DeHoff RM
Clin Pharmacol Ther; 2020 Sep; 108(3):557-565. PubMed ID: 32460360
[TBL] [Abstract][Full Text] [Related]
18. APF2: an improved ensemble method for pharmacogenomic variant effect prediction.
Zhou Y; Pirmann S; Lauschke VM
Pharmacogenomics J; 2024 May; 24(3):17. PubMed ID: 38802404
[TBL] [Abstract][Full Text] [Related]
19. Actionable pharmacogenetic variants in Hong Kong Chinese exome sequencing data and projected prescription impact in the Hong Kong population.
Yu MHC; Chan MCY; Chung CCY; Li AWT; Yip CYW; Mak CCY; Chau JFT; Lee M; Fung JLF; Tsang MHY; Chan JCK; Wong WHS; Yang J; Chui WCM; Chung PHY; Yang W; Lee SL; Chan GCF; Tam PKH; Lau YL; Tang CSM; Yeung KS; Chung BHY
PLoS Genet; 2021 Feb; 17(2):e1009323. PubMed ID: 33600428
[TBL] [Abstract][Full Text] [Related]
20. Implementation of pharmacogenomics into inpatient general medicine.
Chen T; O'Donnell PH; Middlestadt M; Ruhnke GW; Danahey K; van Wijk XMR; Choksi A; Knoebel R; Hartman S; Yeo KJ; Friedman PN; Ratain MJ; Nutescu EA; O'Leary KJ; Perera MA; Meltzer DO
Pharmacogenet Genomics; 2023 Feb; 33(2):19-23. PubMed ID: 36729768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
